Transcode Therapeutics, Inc. (RNAZ) — Net Income
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$34.66M | -106.9% |
| 2024 | -$16.75M | +9.7% |
| 2023 | -$18.55M | -5.6% |
| 2022 | -$17.56M | -156.7% |
| 2021 | -$6.84M | -192.0% |
| 2020 | -$2.34M | — |
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$34.66M | -106.9% |
| 2024 | -$16.75M | +9.7% |
| 2023 | -$18.55M | -5.6% |
| 2022 | -$17.56M | -156.7% |
| 2021 | -$6.84M | -192.0% |
| 2020 | -$2.34M | — |